{"filings":[{"id":2448756,"accession_number":"0001575872-26-000609","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2026-08-25T12:37:42+00:00","items":["1.01","2.01","3.02","9.01"],"status":"ready","headline":"Nu-Med Plus closes acquisition of six Canadian gold properties via Maritimes Gold Corp","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closing on Aug 20, 2026; issued 500,000 Series A Preferred shares to MegumaGold, convertible to up to 10M common shares (20 votes each).","Granted 5.0% net smelter returns royalties on each of: Elmtree, Newfoundland, Killag, Goldenville, Miller Lake, Caribou properties.","MegumaGold shareholders approved deal Aug 10, 2026 with 84.5% voting in favor.","Contingent value: if proceeds from share sales <$3M by 3rd anniversary, Nu-Med issues additional shares (capped at 10% of outstanding).","Treated as asset acquisition; no historical financials or pro forma filed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1580957,"accession_number":"0001575872-26-000494","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2026-07-10T20:15:27+00:00","items":["1.01","3.02","5.01","2.01","5.02","3.03","5.03","7.01","9.01"],"status":"ready","headline":"Nu-Med Plus completes acquisition of Avid Gold; Fred Tejada gains voting control","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 100% of Avid Gold Ltd for 4,500,000 Series A Preferred shares and assumption of $100,000 note.","Fred Tejada appointed director and Sr. VP/Chief Geologist; received 1,000,000 Series X shares with 100 votes each.","Change in control: Tejada controls ~44.5% of voting power via Series X and voting agreement with existing holders.","Company to seek shareholder approval for 1-for-27 reverse split, increase authorized common to 500M, and redomicile to Nevada.","Director Jeffrey Robins resigned; consulting agreements for CEO and CFO at $5,000/month each, contingent on raising $1M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1342397,"accession_number":"0001575872-26-000459","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2026-06-30T11:00:39+00:00","items":["1.01","3.02","3.03","5.03","9.01"],"status":"ready","headline":"Nu-Med Plus to acquire Avid Gold Ltd and six gold properties in Canada via share exchange","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquires 100% of Avid Gold Ltd for 4,500,000 Series A Preferred shares and assumption of $100,000 debt.","Also acquires six gold mineral properties in Nova Scotia, New Brunswick, Newfoundland with 622,332 oz gold resource (45,391 Indicated, 576,942 Inferred).","Post-closing requires shareholder approval for 1-for-27 reverse split, increase authorized shares to 500M, redomicile to Nevada.","New leadership: Emma Priestley as President, William Hayde as Chairman, Keith Merrell as CFO; Jeffrey Robins resigns as director.","Closing expected by July 8, 2026, subject to conditions including shareholder vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191083,"accession_number":"0001548123-24-000118","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.01","3.02","5.01","5.02"],"status":"ready","headline":"Nu-Med Plus acquisition by YourSpace terminated; CEO Russ Colvin resigns, William Hayde appointed CEO","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["YourSpace terminated share exchange agreement on Oct 28, 2024, failing to provide audited 2023 financials.","Russ Colvin resigned as President/CEO and Director upon termination; William Hayde appointed as President/CEO.","No change in control occurred; no securities were issued under the agreement.","William Hayde remains Executive Chairman; Keith Merrell continues as CFO and Director; Jeffrey Robins continues as Director."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224993,"accession_number":"0001548123-24-000067","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.01","3.03","3.02","1.01","5.01","5.02","9.01"],"status":"ready","headline":"Nu-Med Plus completes acquisition of YourSpace America, new CEO and majority control shift","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Nu-Med Plus acquires YourSpace America via share exchange; YSA becomes wholly owned subsidiary as of April 28, 2024.","Consideration: 4.5M shares of Series A Preferred (convertible to 90M common shares, 20:1 voting) and 1M Series X Preferred (100:1 voting).","Series X Preferred issued to William R. Colvin, granting him majority voting control of the combined company.","William R. Colvin appointed President, CEO, and Director; former CEO William Hayde becomes Executive Chairman.","An audit of YSA for the prior two fiscal years is pending; amended 8-K to be filed upon completion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224992,"accession_number":"0001548123-24-000062","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2024-04-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Nu-Med Plus to merge with YourSpace America; YSA's Colvin to become CEO with majority voting control","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["4,500,000 Series A Preferred shares (20:1 voting, convertible into 20 common each) issued to YSA shareholders at closing.","1,000,000 Series X Preferred shares (100:1 voting, non-convertible) issued to YSA CEO Russ Colvin, granting majority voting control.","Upon closing, Colvin becomes President, CEO, Director; William Hayde named Executive Chairman; Merrell and Robins continue as Directors.","Closing subject to final due diligence; no purchase price or financial terms disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":297140,"accession_number":"0001548123-23-000115","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2023-05-24T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Nu-Med Plus enters non-binding LOI to merge with YourSpace America","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["LOI signed May 15, 2023; YourSpace America (YSA) to merge into Nu-Med Plus.","Capital reorganization includes new preferred stock: liquidation preference, 100:1 voting, 20:1 conversion to common.","Stock recipients subject to 180-day lock-up; 6-month exclusivity barring third-party talks.","Transaction subject to due diligence and definitive agreements; each party bears own expenses.","Company will assume all YSA liabilities; preferred stock used as consideration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317515,"accession_number":"0001548123-23-000029","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2023-02-21T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Nu-Med Plus dismisses auditor Sadler, Gibb & Associates, engages Fruci & Associates","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Dismissed Sadler, Gibb & Associates on Feb 17, 2023; no disagreements on accounting principles or audit scope.","Engaged Fruci & Associates as new independent registered public accounting firm on same date.","Prior auditor's report for FY 2021 and 2020 modified only for going concern uncertainty; no adverse opinion.","No reportable events under Reg S-K Item 304(a)(1)(v) during the two fiscal years or subsequent interim period.","Former auditor provided letter of agreement attached as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335748,"accession_number":"0001548123-22-000208","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2022-11-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Nu-Med Plus issues $100K convertible promissory note to Your Space, Inc.","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued 5% convertible promissory note for $100,000 to Your Space, Inc., due December 31, 2023.","Your Space, Inc. is a self-storage development company with projects in Las Vegas, Phoenix, and California.","Note issued on November 18, 2022; no conversion price or other terms disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335746,"accession_number":"0001548123-22-000212","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K/A","filed_at":"2022-11-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Nu-Med Plus issues $100K convertible note to Your Space Inc., due Dec 31, 2023","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued 5% Convertible Promissory Note for $100,000 to Your Space, Inc. on Nov 18, 2022.","Note matures December 31, 2023.","Your Space, Inc. focuses on developing self-storage facilities in US markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335747,"accession_number":"0001548123-22-000151","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2022-10-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Nu-Med Plus appoints Jeffrey L. Robins to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["On October 18, 2022, Board unanimously appointed Jeffrey L. Robins as an additional member.","Appointment fills a recognized need for increased board membership.","No other changes to officer positions or compensation disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353184,"accession_number":"0001548123-22-000147","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2022-09-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CEO Jeffrey Robins resigns; William Hayde appointed as CEO and Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeffrey L. Robins resigned as President, CEO, Director and Chairman on Sept 12, 2022; Dr. Brett J. Earl resigned as director.","William Hayde appointed as President, CEO, Director and Chairman; granted an Employment Agreement.","Company authorized issuance of 2,000,000 restricted shares to Hayde Family Revocable Trust for past services.","Keith L. Merrell, CFO, entered new Employment Agreement replacing the prior 2018 agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":389901,"accession_number":"0001548123-22-000001","cik":1543637,"company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","form_type":"8-K","filed_at":"2022-01-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Nu-Med Plus announces resignation of three officers/directors; Dr. Morrison moves to advisory board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Thomas Tate resigned as VP of Scientific Development and director, effective Dec 31, 2021.","William Moon resigned as VP of Technology and director, effective Dec 31, 2021.","Dr. Craig Morrison resigned as VP of Research and director; he will join the Medical Advisory Board.","All resignations are for personal reasons and without any disputes with the Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":852194.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}